Quantcast

Latest Diabetes management Stories

2014-10-21 12:32:35

WORCESTER, Mass., Oct. 21, 2014 /PRNewswire/ -- Grove Instruments Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that the Company has achieved a landmark clinical milestone known internally as "durable calibration." "This achievement was the last hurdle on the critical path to commercialization of our first product," explained Arthur Combs, Grove's CEO. "We have already identified our initial target markets...

2014-10-21 08:34:10

RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults with type 2 diabetes (T2D). Empagliflozin plus metformin is part of the Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) Diabetes alliance portfolio. "Type 2...

2014-10-21 08:33:10

Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced today that the first patient participating in the company's first broad study of the ssAir Bio-Artificial Pancreas has been successfully implanted. ssAir is in development as a treatment and a potential cure for type 1 diabetes (T1D). Approximately 3 million people have T1D in the...

2014-10-21 08:29:17

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Lazar Partners, a strategic communications firm for companies in the biopharma and medical device space, today announced the firm has been named the recipient of two PR Agency Elite awards by PR News for their work with partner Insulet Corporation on the diabetes blog, Suite D. Lazar Partners was nominated as a finalist and received honorable mention awards in both the Advocacy and Content Marketing categories. Winners were announced at PR...

2014-10-20 23:03:14

DiabetesSisters thanks strategic partner and 2014 Weekend for Women conference Premier Sponsor Sanofi DURHAM, NC (PRWEB) October 20, 2014 The 2014 Weekend for Women is guaranteed to be an event filled with sisterhood, learning opportunities, and community building. It would not be possible without the commitment of attendees and conference presenters, as well as charitable contributions from corporations dedicated to heath-promotion and education. Four days away from the start of the...

2014-10-20 16:27:26

RARITAN, N.J., Oct. 20, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. has teamed up with the Diabetes Hands Foundation to raise awareness about the importance of incorporating physical activity into a comprehensive diabetes management approach. During National Diabetes Month in November, the companies are calling upon people with diabetes to experience the impact small steps, like dancing, can have on their health through the T2 Dance Crew(TM) and Big Blue Test programs. The...

2014-10-20 08:32:52

Dario market reach continues to broaden with initial penetration into North America CAESAREA, Israel, Oct. 20, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIOD), developer of the Dario(TM) Diabetes Management Solution, today announced that it will exhibiting and demonstrating together with Auto Control Medical Inc. at the 17th Annual Canada Diabetes Association CDA/CSEM Professional Conference and Annual Meetings in Winnipeg, Manitoba at the RBC Convention Center from...

2014-10-16 12:29:31

Prescribers Are Enthusiastic about the SGLT-2 Inhibitors, but Payers Are Not Fully Convinced of the Added Benefits of These Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of type 2 diabetes, over 90 percent of surveyed physicians in South Korea and Taiwan indicated that they would use SGLT-2 inhibitors when they become available, and over the next three years these emerging...

2014-10-15 08:31:35

Market reach continues to broaden with positive feedback and interest for the Dario(TM) Diabetes Management Solution CAESAREA, Israel, Oct. 15, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIOD), developer of the Dario(TM) Diabetes Management Solution, today announced that it is ramping up its market reach over the coming months with the initial product launch in Canada and the Netherlands. The launch of Dario(TM) in Canada and the Netherlands represents a positive continuation of...

2014-10-15 08:30:11

BRIDGEWATER, N.J., Oct. 15, 2014 /PRNewswire/ -- Sanofi US announced today the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes and available treatment options. In particular, the generation known as "millennials" (those aged 18 to 34) shows an uneasy mix of fear and ability to handle managing their diabetes, which is being diagnosed at a rate of 1.7 million new cases every year(1). Millennials rate themselves having better...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.